Skip to content

Can Testosterone Accelerate Injury Recovery After Arthroscopic Rotator Cuff Repair

A Randomized, Blinded Controlled Trial to Determine if Testosterone Can Accelerate Injury Recovery After Arthroscopic Rotator Cuff Repair

Status
Withdrawn
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04345666
Enrollment
0
Registered
2020-04-14
Start date
2021-08-31
Completion date
2023-01-31
Last updated
2022-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Tears

Keywords

arthroscopic rotator cuff repair, testosterone, accelerate recovery from surgery

Brief summary

The objective of this study is to determine if treating patients undergoing arthroscopic rotator cuff repair with testosterone will allow patients to accelerate their recovery time after surgery.

Detailed description

Specific Aim I: To determine if testosterone treatment would provide superior patient-determined quality-of-life and activity scores in patients undergoing arthroscopic rotator cuff repair compared to a control group at 3 months after surgery. Specific Aim II: To determine if testosterone treatment would allow for greater postoperative strength improvements in patients undergoing arthroscopic rotator cuff repair compared to a control group at 3 months after surgery. Specific Aim III: To determine if testosterone treatment would allow for greater postoperative range of motion improvements in patients undergoing arthroscopic rotator cuff repair compared to a control group at 3 months after surgery. Specific Aim IV: To determine if the potentially higher activity levels allowed by the testosterone treatment would affect the success of rotator cuff healing as determined by magnetic resonance imaging at one year after arthroscopic rotator cuff repair. The hypothesis of this study was that testosterone treatment of patients undergoing arthroscopic rotator cuff repair would allow patients to achieve 1) better quality-of-life and higher activity levels as determined by patient-determined outcome scores, 2) greater improvements in strength, and 3) greater improvements in range of motion at three months after surgery as compared to the control group. In addition, the authors hypothesize that there would be equivalent healing rates at one year after rotator cuff repair as determined by magnetic resonance imaging between the testosterone group and the control group.

Interventions

DRUGTestosterone cypionate

The intervention of this study is to treat patients to either 1) testosterone cypionate or 2) placebo (sterile saline) to determine if there is a difference in recovery times after arthroscopic rotator cuff repair

DRUGPlacebos

The intervention of this study is to treat patients to either 1) testosterone cypionate or 2) placebo (sterile saline) to determine if there is a difference in recovery times after arthroscopic rotator cuff repair

Sponsors

Orthopedic Institute, Sioux Falls, SD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

The patient and the primary investigator will be blinded to the treatment allocation. The study coordinator will be unblinded.

Intervention model description

Randomized, double-blinded, placebo controlled model

Eligibility

Sex/Gender
MALE
Age
45 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Males * arthroscopic rotator cuff repair is an indicated treatment

Exclusion criteria

* female patients * irreparable rotator cuff tears * tears requiring margin convergence repair * atrophy of the rotator cuff greater than stage II as determined by the modified Goutallier staging system * revision rotator cuff repair * inflammatory arthritis * adhesive capsulitis * significant cervical pain or radiculopathy * history of prostate cancer * history of benign prostatic hypertrophy * history of heart failure * history of obstructive sleep apnea * history of polycythemia * history of venous thromboembolism or inherited thrombophilia

Design outcomes

Primary

MeasureTime frameDescription
Single Alpha-Numeric Assessment Evaluation3 months after surgeryA validated general patient-determined outcome score (low 0 - 100 high)
American Shoulder and Elbow Score3 months after surgeryA validated joint specific patient-determined outcome score (low 0 - 100 high)
Simple Shoulder Test3 months after surgeryA validated joint specific patient-determined outcome score (low 0 - 12 high)
Shoulder strength3 months after surgeryDynanometrically measured scaption and external rotation strength (Newtons)
Shoulder Activity Level3 months after surgeryA validated shoulder-specific activity score (low 0 - 20 high)
Shoulder Range of Motion3 months after surgeryGoniometrically-measured (in degrees) Flexion, extension, abduction, external rotation, abducted external rotation, abducted internal rotation, internal rotation behind the back

Secondary

MeasureTime frameDescription
Magnetic resonance imaging shoulder12 months after surgeryMRI

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026